Apellis Pharmaceuticals Inc (APLS)
29.96
+1.22
(+4.24%)
USD |
NASDAQ |
Nov 08, 16:00
29.98
+0.02
(+0.07%)
After-Hours: 20:00
Apellis Pharmaceuticals Research and Development Expense (% of Annual Revenues)
Research and Development Expense (% of Annual Revenues) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (% of Annual Revenues) Data
| Date | Value |
|---|---|
| December 31, 2023 | -- |
| December 31, 2022 | -- |
| Date | Value |
|---|---|
| December 31, 2021 | -- |
| December 31, 2020 | -- |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.